Publicacións nas que colabora con Sabela Paradela de la Morena (21)

2022

  1. Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

    Dermatology and Therapy, Vol. 12, Núm. 3, pp. 761-770

2020

  1. Ustekinumab treatment for moderate to severe psoriasis. Eight-year real-world follow-up of 61 cases in a tertiary level hospital

    Journal of Dermatological Treatment, Vol. 31, Núm. 7, pp. 698-701

2016

  1. Apremilast en dermatología

    Piel, Vol. 31, Núm. 3, pp. 206-215

  2. Positive correlation between etanercept concentration and the decrease in Psoriasis Area and Severity Index scale value

    International Journal of Clinical Pharmacy, Vol. 38, Núm. 5, pp. 1142-1148

2015

  1. Efficacy and safety of adalimumab in psoriatic patients previously treated with etanercept in a real-world setting

    Journal of Dermatological Treatment, Vol. 26, Núm. 3, pp. 217-222

  2. Infliximab drug and antibody levels in patients with dermatological conditions

    International Journal of Clinical Pharmacy, Vol. 37, Núm. 2, pp. 320-326

  3. Long-Term Efficacy of Etanercept for Plaque-Type Psoriasis and Estimated Cost in Daily Clinical Practice

    Value in Health, Vol. 18, Núm. 8, pp. 1158-1161

2014

  1. Guías para el tratamiento de la psoriasis en placas moderada-grave con terapias biológicas

    Terapias biológicas para la psoriasis (Fundación do Complexo Hospitalario Universitario A Coruña), pp. 7

  2. Long-term response to etanercept monotherapy in moderate to severe psoriasis: Assessment in daily practice by the maintenance of low values of PASI and BSA

    Journal of Dermatological Treatment, Vol. 25, Núm. 1, pp. 54-56

2013

  1. Enfermedad por inmunoglobulina A lineal de la infancia

    Piel, Vol. 28, Núm. 4, pp. 199-201

2012

  1. Extirpación de quistes epidérmicos y triquilemales mediante incisión con sacabocados (punch)

    Piel, Vol. 27, Núm. 8, pp. 468-471

  2. Long-term efficacy of infliximab in hidradenitis suppurativa

    Journal of Dermatological Treatment, Vol. 23, Núm. 4, pp. 278-283

  3. Psoriasis in patients older than 65 years. A comparative study with younger adult psoriatic patients

    Journal of Nutrition, Health and Aging, Vol. 16, Núm. 6, pp. 586-591

2011

  1. Congenital langerhans cell histiocytosis involving only one of non-identical twins

    European Journal of Dermatology

  2. Wedge resection of tumors of the outer ear

    Piel, Vol. 26, Núm. 3, pp. 147-149

2010

  1. Infliximab-induced lichen planopilaris

    Annals of Pharmacotherapy, Vol. 44, Núm. 9, pp. 1501-1503

  2. Rosaceiform eruption induced by cetuximab

    European Journal of Dermatology

2009

  1. Controversial issues in congenital nevi

    Actas Dermo-Sifiliograficas, Vol. 100, Núm. 7, pp. 548-561

  2. Refractory discoid lupus erythematosus: Response to efalizumab

    Journal of the European Academy of Dermatology and Venereology

2008

  1. Bowen's disease treated by carbon dioxide laser. A series of 44 patients

    Journal of Dermatological Treatment, Vol. 19, Núm. 5, pp. 293-299